Immunotherapy Gastrict Cancer (1)

Not yet recruiting (1)

phase 2/phase 3 (1)

Fujian Cancer Hospital (1)

apatinib (1)

oxaliplatin (1)

s-1 (1)

tislelizumab (1)

drug (1)

Other (1)

Interventional (1)

immunotherapy gastrict cancer

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Not yet recruiting

Jan 17, 2023